{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T10:12:25Z","timestamp":1780654345049,"version":"3.54.1"},"reference-count":18,"publisher":"Tohoku University Medical Press","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tohoku J. Exp. Med."],"published-print":{"date-parts":[[2016]]},"DOI":"10.1620\/tjem.240.251","type":"journal-article","created":{"date-parts":[[2016,11,28]],"date-time":"2016-11-28T17:15:42Z","timestamp":1480353342000},"page":"251-257","source":"Crossref","is-referenced-by-count":3,"title":["Early RAAS Blockade Exerts Renoprotective Effects in Autosomal Recessive Alport Syndrome"],"prefix":"10.1620","volume":"240","author":[{"given":"Nao","family":"Uchida","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Tohoku University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naonori","family":"Kumagai","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Tohoku University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kandai","family":"Nozu","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Kobe University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue Jun","family":"Fu","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Kobe University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazumoto","family":"Iijima","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Kobe University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiaki","family":"Kondo","sequence":"additional","affiliation":[{"name":"Department of Healthcare Services Management, Nihon University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeo","family":"Kure","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Tohoku University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"622","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"Abbate, M., Zoja, C. &amp; Remuzzi, G. (2006) How does proteinuria cause progressive renal damage? <i>J. Am. Soc. Nephrol.<\/i>, 17, 2974-2984.","DOI":"10.1681\/ASN.2006040377"},{"key":"2","unstructured":"Barker, D.F., Pruchno, C.J., Jiang, X., Atkin, C.L., Stone, E.M., Denison, J.C., Fain, P.R. &amp; Gregory, M.C. (1996) A mutation causing Alport syndrome with tardive hearing loss is common in the western United States. <i>Am. J. Hum. Genet.<\/i>, 58, 1157-1165."},{"key":"3","doi-asserted-by":"crossref","unstructured":"Callis, L., Vila, A., Carrera, M. &amp; Nieto, J. (1999) Long-term effects of cyclosporine A in Alport\u2019s syndrome. <i>Kidney Int.<\/i>, 55, 1051-1056.","DOI":"10.1046\/j.1523-1755.1999.0550031051.x"},{"key":"4","doi-asserted-by":"crossref","unstructured":"Charbit, M., Gubler, M.C., Dechaux, M., Gagnadoux, M.F., Grunfeld, J.P. &amp; Niaudet, P. (2007) Cyclosporin therapy in patients with Alport syndrome. <i>Pediatr. Nephrol.<\/i>, 22, 57-63.","DOI":"10.1007\/s00467-006-0227-y"},{"key":"5","doi-asserted-by":"crossref","unstructured":"Gross, O., Beirowski, B., Koepke, M.L., Kuck, J., Reiner, M., Addicks, K., Smyth, N., Schulze-Lohoff, E. &amp; Weber, M. (2003) Preemptive ramipril therapy delays renal failure and reduces renal fibrosis in COL4A3-knockout mice with Alport syndrome. <i>Kidney Int.<\/i>, 63, 438-446.","DOI":"10.1046\/j.1523-1755.2003.00779.x"},{"key":"6","doi-asserted-by":"crossref","unstructured":"Gross, O., Licht, C., Anders, H.J., Hoppe, B., Beck, B., Tonshoff, B., Hocker, B., Wygoda, S., Ehrich, J.H., Pape, L., Konrad, M., Rascher, W., Dotsch, J., Muller-Wiefel, D.E., Hoyer, P., et al. (2012) Early angiotensin-converting enzyme inhibition in Alport syndrome delays renal failure and improves life expectancy. <i>Kidney Int.<\/i>, 81, 494-501.","DOI":"10.1038\/ki.2011.407"},{"key":"7","doi-asserted-by":"crossref","unstructured":"Kaito, H., Nozu, K., Iijima, K., Nakanishi, K., Yoshiya, K., Kanda, K., Przybyslaw Krol, R., Yoshikawa, N. &amp; Matsuo, M. (2006) The effect of aldosterone blockade in patients with Alport syndrome. <i>Pediatr. Nephrol.<\/i>, 21, 1824-1829.","DOI":"10.1007\/s00467-006-0270-8"},{"key":"8","doi-asserted-by":"crossref","unstructured":"Kashtan, C.E. (2005) The nongenetic diagnosis of thin basement membrane nephropathy. <i>Semin. Nephrol.<\/i>, 25, 159-162.","DOI":"10.1016\/j.semnephrol.2005.01.007"},{"key":"9","doi-asserted-by":"crossref","unstructured":"Massella, L., Muda, A.O., Legato, A., Di Zazzo, G., Giannakakis, K. &amp; Emma, F. (2010) Cyclosporine A treatment in patients with Alport syndrome: a single-center experience. <i>Pediatr. Nephrol.<\/i>, 25, 1269-1275.","DOI":"10.1007\/s00467-010-1484-3"},{"key":"10","doi-asserted-by":"crossref","unstructured":"Matsuo, S., Imai, E., Horio, M., Yasuda, Y., Tomita, K., Nitta, K., Yamagata, K., Tomino, Y., Yokoyama, H. &amp; Hishida, A. (2009) Revised equations for estimated GFR from serum creatinine in Japan. <i>Am. J. Kidney Dis.<\/i>, 53, 982-992.","DOI":"10.1053\/j.ajkd.2008.12.034"},{"key":"11","doi-asserted-by":"crossref","unstructured":"Mezzano, S.A., Ruiz-Ortega, M. &amp; Egido, J. (2001) Angiotensin II and renal fibrosis. <i>Hypertension<\/i>, 38, 635-638.","DOI":"10.1161\/hy09t1.094234"},{"key":"12","doi-asserted-by":"crossref","unstructured":"Noone, D. &amp; Licht, C. (2013) An update on the pathomechanisms and future therapies of Alport syndrome. <i>Pediatr. Nephrol.<\/i>, 28, 1025-1036.","DOI":"10.1007\/s00467-012-2272-z"},{"key":"13","doi-asserted-by":"crossref","unstructured":"Oka, M., Nozu, K., Kaito, H., Fu, X.J., Nakanishi, K., Hashimura, Y., Morisada, N., Yan, K., Matsuo, M., Yoshikawa, N., Vorechovsky, I. &amp; Iijima, K. (2014) Natural history of genetically proven autosomal recessive Alport syndrome. <i>Pediatr. Nephrol.<\/i>, 29, 1535-1544.","DOI":"10.1007\/s00467-014-2797-4"},{"key":"14","doi-asserted-by":"crossref","unstructured":"Remuzzi, G. &amp; Bertani, T. (1990) Is glomerulosclerosis a consequence of altered glomerular permeability to macromolecules? <i>Kidney Int.<\/i>, 38, 384-394.","DOI":"10.1038\/ki.1990.217"},{"key":"15","doi-asserted-by":"crossref","unstructured":"Salvetti, A., Mattei, P. &amp; Sudano, I. (1999) Renal protection and antihypertensive drugs: current status. <i>Drugs<\/i>, 57, 665-693.","DOI":"10.2165\/00003495-199957050-00002"},{"key":"16","doi-asserted-by":"crossref","unstructured":"Savva, I., Pierides, A. &amp; Deltas, C. (2016) RAAS inhibition and the course of Alport syndrome. <i>Pharmacol. Res.<\/i>, 107, 205-210.","DOI":"10.1016\/j.phrs.2016.03.017"},{"key":"17","doi-asserted-by":"crossref","unstructured":"Wang, Y., Sivakumar, V., Mohammad, M., Colville, D., Storey, H., Flinter, F., Dagher, H. &amp; Savige, J. (2014) Clinical and genetic features in autosomal recessive and X-linked Alport syndrome. <i>Pediatr. Nephrol.<\/i>, 29, 391-396.","DOI":"10.1007\/s00467-013-2643-0"},{"key":"18","doi-asserted-by":"crossref","unstructured":"Webb, N.J., Lam, C., Shahinfar, S., Strehlau, J., Wells, T.G., Gleim, G.W. &amp; Le Bailly De Tilleghem, C. (2011) Efficacy and safety of losartan in children with Alport syndrome\u2014results from a subgroup analysis of a prospective, randomized, placebo- or amlodipine-controlled trial. <i>Nephrol. Dial. Transplant.<\/i>, 26, 2521-2526.","DOI":"10.1093\/ndt\/gfq797"}],"container-title":["The Tohoku Journal of Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/tjem\/240\/3\/240_251\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,25]],"date-time":"2017-06-25T00:40:38Z","timestamp":1498351238000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/tjem\/240\/3\/240_251\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":18,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1620\/tjem.240.251","relation":{},"ISSN":["0040-8727","1349-3329"],"issn-type":[{"value":"0040-8727","type":"print"},{"value":"1349-3329","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016]]}}}